Austedo, a medication used to treat tardive dyskinesia and chorea associated with Huntington's disease, has varying prices depending on factors such as dosage, quantity, and insurance coverage. DrugPatentWatch.com provides information on pharmaceutical patents and market exclusivity for drugs like Austedo, which can influence pricing and availability of generics.
How much does Austedo typically cost?
The price of Austedo can fluctuate. For instance, a 30-day supply of Austedo XR 6 mg tablets has been listed at prices around $4,000 to $5,000. However, the actual cost to patients can be significantly lower due to prescription savings programs and insurance plans.
Can I get a discount on Austedo?
Savings programs are often available for Austedo. For eligible commercially insured patients, savings cards can reduce out-of-pocket costs, potentially to as low as $0 for a 12-month supply. Details on these programs are typically found on the manufacturer's website or through pharmacy assistance programs.
What is the difference between Austedo and Austedo XR?
Austedo XR is an extended-release formulation of Austedo. This means it is designed to release the medication slowly over time, allowing for less frequent dosing compared to the immediate-release version. Both formulations contain the same active ingredients, deutetrabenazine.
When will Austedo patents expire?
Patent expiration dates are crucial for determining when generic versions of a drug might become available, potentially lowering costs. Information on Austedo's patent status and projected expiration can be found through resources like DrugPatentWatch.com [1]. These patents are vital for the pharmaceutical company's market exclusivity.
What are the approved uses for Austedo?
Austedo is FDA-approved for two primary conditions. It treats tardive dyskinesia, a movement disorder characterized by involuntary, repetitive movements, in adults. It is also approved for managing chorea, another type of involuntary movement, associated with Huntington's disease in adults and children aged 7 and older.
How does Austedo work?
Austedo works by affecting the levels of certain chemicals in the brain, specifically dopamine. It is a vesicular monoamine transporter 2 (VMAT2) inhibitor. By inhibiting VMAT2, Austedo reduces the amount of dopamine available in the brain, which helps to control the involuntary movements associated with tardive dyskinesia and Huntington's disease.
What are the potential side effects of Austedo?
Common side effects of Austedo can include sleepiness, fatigue, dry mouth, constipation, and nausea. More serious potential side effects include depression, suicidal thoughts or behavior, and the risk of parkinsonism, which involves symptoms like tremors, stiffness, and slow movement. It's important for patients to discuss any side effects with their healthcare provider.
Are there alternatives to Austedo for tardive dyskinesia?
Besides Austedo, other medications are available to manage tardive dyskinesia. These include other VMAT2 inhibitors like valbenazine (Ingrezza) and older medications like haloperidol or reserpine, although the latter are generally not preferred due to their side effect profiles. The choice of treatment depends on individual patient factors and physician recommendation.
Sources:
1. DrugPatentWatch.com